SCHEMBL2655101

SCHEMBL2655101

COC(=O)CCNC(=O)c1ccc(CCC(C)COc2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESRRG P62508 6/20 0.49
▸ NR1H4 Q96RI1 5/20 0.49
▸ EPHX2 P34913 4/20 0.49
▸ ESRRB O95718 1/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ ADRB2 P07550 1/20 0.47
▸ ADRB1 P08588 1/20 0.47
▸ CA1 P00915 3/20 0.45
▸ CA2 P00918 3/20 0.45
▸ CA12 O43570 2/20 0.44
▸ CA9 Q16790 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657119 0.97 NR1H4 (0.47) ESRRGNR1H4EPHX2ESRRBL3MBTL1
SCHEMBL2654353 0.91 NR1H4 (0.54) ESRRGNR1H4EPHX2ESRRBL3MBTL1
SCHEMBL2662283 0.88 MEN1 (0.46) MEN1KMT2AADRB2ADRB1CA1
SCHEMBL2653577 0.88 GCGR (0.51) ESRRGNR1H4EPHX2ESRRBL3MBTL1
SCHEMBL2655270 0.88 GCGR (0.53) ESRRGNR1H4EPHX2ESRRBL3MBTL1
SCHEMBL2657309 0.87 ESRRG (0.53) ESRRGNR1H4EPHX2ESRRBL3MBTL1
SCHEMBL2653943 0.87 NR1H4 (0.48) ESRRGNR1H4EPHX2ESRRBL3MBTL1
SCHEMBL2653571 0.82 ADRB2 (0.41) ESRRGNPC1RAB9AMEN1KMT2A
SCHEMBL2653054 0.82 CA12 (0.42) MEN1KMT2AADRB2ADRB1CA1
SCHEMBL2655436 0.81 NPC1 (0.55) ESRRGNR1H4EPHX2ESRRBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 — — EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 — — WO disclosed
Send feedback